Grace gene therapy is a revolutionary gene therapy treatment approach and groundbreaking solution to Parkinson’s disease, first in class chemo genetic agent, without competitor in the market. The unique treatment selectively targets the diseased region by precise biological brain neuromodulator, unlike the mainstream treatment today, which is based on the dopaminergic system.
The bio-tech treatment helps fix the neural network problems caused by Parkinson’s disease. It does this by adjusting certain parts of the brain (the basal ganglia) using special chemical tools called DREADDs (Designer Receptors Exclusively Activated by Designer Drugs). Neuroscientists now use DREADDs-based tools a lot. These tools help them study the brain circuits and signals that control things like behaviour, perceptions, emotions, natural drives, and movement in different species, from flies to non-human primates.
